"European equities pushed higher at the start of the week, led by financials, with the CAC 40 up 1.25% and outperforming peers despite Fitch cutting France's sovereign credit rating from AA- to A+. Despite the strength of the financial sector, the FTSE 100 has lagged its mainland counterparts thanks to a decline across healthcare stocks after AstraZeneca (3.6%) paused a £200 million investment into their UK headquarters."
"Asian equities traded mixed to start the week, with Japan's Nikkei 225 climbing 0.9% while Chinese markets lagged. The Hang Seng added 0.22%, extending gains for a second session, even as the Shanghai Composite slipped 0.26%. Investor sentiment was supported by ongoing US-China trade negotiations in Madrid, which entered their second day and signalled stepped-up diplomatic engagement. Still, optimism was tempered by disappointing Chinese data."
European equities rose at the start of the week, led by financials, with the CAC 40 up 1.25% despite Fitch cutting France's sovereign rating from AA- to A+. The FTSE 100 lagged mainland peers after healthcare stocks fell when AstraZeneca paused a £200 million investment in its UK headquarters. Markets await policy decisions from the Fed, Bank of England, Bank of Canada, and Bank of Japan, with the Fed widely expected to deliver the first 2025 rate cut. Asian markets were mixed as Japan climbed while Chinese markets lagged amid weak industrial production, slowing retail sales, and rising unemployment, and US-China negotiations and regulatory rulings influenced sentiment.
Read at London Business News | Londonlovesbusiness.com
Unable to calculate read time
Collection
[
|
...
]